Overview of current clinical registries

Oncology, radiotherapy

 Directory of registries

BIOMARKERY PANKREAS

Evaluation of efficacy of new spectroscopic biomarkers for the detection of early-stage pancreatic cancer.

CAMELIA – Chronic MyEloid LeukaemIA

International clinical registry of patients with chronic myeloid leukaemia.

Cervix.cz – Cervical Cancer Screening Programme in the Czech Republic

System of informational support for the Cervical Cancer Screening Programme in the Czech Republic.

CLLEAR

Clinical registry of patients with chronic lymphocytic leukaemia (CLL).

CyRUS – Cystectomy Registry of the Czech Urological Society

Clinical registry monitoring cases of bladder cancers treated with cystectomy and consecutive treatment.

DATOOL ALL

Clinical registry of patients with acute lymphoblastic leukaemia (ALL).

DATOOL AML

Clinical registry of patients with acute myeloid leukaemia (AML).

DoIT!

Non-interventional, multicentre, retrospective and prospective study of patients with brain tumours, who have been treated in the Czech Republic according to the common clinical practice.

FIND

Clinical registry of haemato-oncological patients in which antimycotic therapy has been administered.

Infinity

Clinical registry of patients with chronic myeloid leukaemia (CML).

KELLY

Registry of EGFR mutation testing results in patients with non-small-cell lung cancer (NSCLC) in the Czech Republic.

Kolorektum.cz – Colorectal Cancer Screening Programme in the Czech Republic

System of informational support for the Colorectal Cancer Screening Programme in the Czech Republic.

Mamo.cz – Breast Cancer Screening Programme in the Czech Republic

System of informational support for the Breast Cancer Screening Programme in the Czech Republic.

MDS – MyeloDysplastic Syndrome

Clinical registry of patients with myelodysplastic syndrome.

MELANOM - data collection on patients with melanoma.

The MELANOM registry is a time-limited non-interventional post-authorization data collection on patients with melanoma. The project aims to monitor patients with modern expensive treatment of advanced disease and also monitoring of patients with adjuvant treatment. Data collection started in December 2020. The duration of the study is planned for 5 years (until the end of 2025).

MIND

Clinical registry of patients with myeloproliferative disorders.

NET – NEuroendocrine Tumours

Český registr neuroendokrinních nádorů.

RENIS II - Registry of patients with renal cell carcinoma

The RENIS II project is intended to cover the monitoring of patients with renal cell carcinoma (RCC).